Conversion Disorder
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Do the Lifetime Prevalence and Prognosis of Schizophrenia Differ Among World Regions? Cheryl Lynn Smith
Claremont Colleges Scholarship @ Claremont CMC Senior Theses CMC Student Scholarship 2018 Do the Lifetime Prevalence and Prognosis of Schizophrenia Differ Among World Regions? Cheryl Lynn Smith Recommended Citation Smith, Cheryl Lynn, "Do the Lifetime Prevalence and Prognosis of Schizophrenia Differ Among World Regions?" (2018). CMC Senior Theses. 1978. http://scholarship.claremont.edu/cmc_theses/1978 This Open Access Senior Thesis is brought to you by Scholarship@Claremont. It has been accepted for inclusion in this collection by an authorized administrator. For more information, please contact [email protected]. Do the Lifetime Prevalence and Prognosis of Schizophrenia Differ Among World Regions? A Thesis Presented by Cheryl Lynn Smith To the Keck Science Department Of Claremont McKenna, Pitzer, and Scripps Colleges In partial fulfillment of The degree of Bachelor of Arts Senior Thesis in Human Biology 04/23/2018 LIFETIME PREVALENCE AND PROGNOSIS OF SCHIZOPHRENIA 1 Table of Contents Abstract …………………………………………………………...……………………… 2 1. Introduction………………………………………………...…………...……………… 3 2. Background Information ……………………………...……………………………….. 5 2.1 Historical Background of Schizophrenia ……………………....…………… 5 2.2 Lifetime Prevalence of Schizophrenia …………………………...…..……… 12 2.3 Prognosis in People with Schizophrenia ……………....………...…..……… 13 3. Methods …………………………………………...……………………..……………. 17 4. Results ……………………………………………...…………………….…….…….... 18 5. Discussion ……………………………………………...……………………………… 24 6. Acknowledgements …………………………………………...………………………. -
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain Infectious and Parasitic Diseases (A00-B99)
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain infectious and parasitic diseases (A00-B99) No Change Intestinal infectious diseases (A00-A09) No Change A04 Other bacterial intestinal infections No Change A04.7 Enterocolitis due to Clostridium difficile Add A04.71 Enterocolitis due to Clostridium difficile, recurrent Add A04.72 Enterocolitis due to Clostridium difficile, not specified as recurrent No Change A05 Other bacterial foodborne intoxications, not elsewhere classified No Change Excludes1: Revise from Clostridium difficile foodborne intoxication and infection (A04.7) Revise to Clostridium difficile foodborne intoxication and infection (A04.7-) No Change Helminthiases (B65-B83) No Change B81 Other intestinal helminthiases, not elsewhere classified No Change Excludes1: Revise from angiostrongyliasis due to Parastrongylus cantonensis (B83.2) Revise to angiostrongyliasis due to: Add Angiostrongylus cantonensis (B83.2) Add Parastrongylus cantonensis (B83.2) No Change B81.3 Intestinal angiostrongyliasis Revise from Angiostrongyliasis due to Parastrongylus costaricensis Revise to Angiostrongyliasis due to: Add Angiostrongylus costaricensis Add Parastrongylus costaricensis No Change Chapter 2 No Change Neoplasms (C00-D49) No Change Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80) No Change C79 Secondary malignant neoplasm of other and unspecified sites Delete Excludes2: lymph node metastases (C77.0) No Change C79.1 Secondary malignant neoplasm of bladder -
EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF -
Conversion Disorder in a Depressed Patient: the Analysis of Paralysis
Jefferson Journal of Psychiatry Volume 16 Issue 1 Article 3 January 2001 Conversion Disorder in a Depressed Patient: The Analysis of Paralysis Michael A. Chen Ph.D. University of Michigan Medical School, Ann Arbor, MI David S. Im M.D. Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, MI Follow this and additional works at: https://jdc.jefferson.edu/jeffjpsychiatry Part of the Psychiatry Commons Let us know how access to this document benefits ouy Recommended Citation Chen, Michael A. Ph.D. and Im, David S. M.D. (2001) "Conversion Disorder in a Depressed Patient: The Analysis of Paralysis," Jefferson Journal of Psychiatry: Vol. 16 : Iss. 1 , Article 3. DOI: https://doi.org/10.29046/JJP.016.1.002 Available at: https://jdc.jefferson.edu/jeffjpsychiatry/vol16/iss1/3 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Jefferson Journal of Psychiatry by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. Conversion Disorder in a Depressed Patient: The Analysis of Paralysis 2 Michael A. Chen, Ph.D. I and David S. -
Functional Neurologic Disorders and Related Disorders Victor W Mark MD ( Dr
Functional neurologic disorders and related disorders Victor W Mark MD ( Dr. Mark of the University of Alabama at Birmingham has no relevant financial relationships to disclose. ) Originally released April 18, 2001; last updated December 13, 2018; expires December 13, 2021 Introduction This article includes discussion of psychogenic neurologic disorders, functional neurologic disorder, functional movement disorder, conversion disorder, and hysteria. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations. Overview Several behavioral disorders are related by (1) their resemblance to other, more familiar neurologic disorders; (2) lack of well-established biomarkers (eg, structural lesions on brain imaging studies, seizure waveforms on EEGs); and (3) aggravation of symptoms with the patient s attention to the disorder. However, the features and causes for these disorders are very different among themselves. This topic reviews functional neurologic disorder, Munchausen syndrome, Munchausen syndrome by proxy, and Ganser syndrome. Key points • Functional neurologic disorders are commonly encountered in general neurologic practices and, hence, knowing their manifestations and treatment is crucial for clinical care. • The disturbance is involuntary, yet at the same time it can be controlled by the patient intermittently. • Despite being self-controllable, the disturbance is generally disabling unless expert professional care is provided. • There is no consistent association between functional neurologic disorder and either posttraumatic emotional stress or sexual abuse. • Functional neurologic disturbances disorder responds best to empathetic concern by the clinician; demonstration that the disorder lacks a structural or permanent etiology; explanation that it can be improved with distraction; and guided attempts to reduce triggers of onset. Cognitive behavioral therapy, combined with physical therapy when warranted, is emerging as a successful intervention. -
Stem Cells and Neurological Disease the Transplant Site
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.5.553 on 1 May 2003. Downloaded from EDITORIAL 553 Stem cells shown to survive and ameliorate behav- ................................................................................... ioural deficits in an animal mode of Par- kinson’s disease,3 although in this study 20% of rats still developed teratomas at Stem cells and neurological disease the transplant site. In contrast, Kim et al, using a different approach that relies on R A Barker, M Jain,RJEArmstrong, M A Caldwell transfection with Nurr1 (a transcription ................................................................................... factor involved in the differentiation of dopaminergic cells), have demonstrated The therapeutic implications and application of stem cells for functional efficacy without tumour formation.4 the nervous system Human embryonic stem cells have now been isolated5 and grown in culture with enrichment for neuronal lineages, here has recently been a great deal of (c) ability to migrate and disseminate possible through exposure to a combina- interest in stem cells and the nerv- following implantation within the adult tion of growth factors and mitogens.6 Tous system, in terms of their poten- CNS; These cells, when placed in the develop- tial for deciphering developmental issues (d) possible tropism for areas of path- ing rat brain, can migrate widely and as well as their therapeutic potential. In ology; differentiate in a site specific fashion this editorial we will critically appraise without the formation of teratomas.7 the different types of stem cells, their (e) ease of manipulation using viral and non-viral gene transfer methods; However, the safety of these cells needs therapeutic implications, and the appli- further investigation before they can be (f) ability to better integrate into normal cations to which they have been put, considered for clinical use. -
Primer Progressive Aphasia with Psychiatric Symptoms
Case Report iMedPub Journals ACTA PSYCHOPATHOLOGICA 2017 http://www.imedpub.com ISSN 2469-6676 Vol. 3 No. 4: 36 DOI: 10.4172/2469-6676.100108 Primer Progressive Aphasia with Psychiatric Metehan Yildirim1, Gülfizar Sözeri-Varma1*, Symptoms Çağatay Öncel2, Ibrahim Şendur1 and Osman Özdel1 Abstract 1 Department of Psychiatry, Pamukkale Primary Progressive Aphasia (PPA) is a rare neurodegenerative disease that is University, Denizli, Turkey rarely observed with the relative preservation of mental functions such as memory, 2 Department of Neurology, Pamukkale visuospatial functions, personal characteristics but that causes degeneration of University, Denizli, Turkey speech function. Even though cognitive and behavioral functions are preserved during the starting stages, psychiatric symptoms may develop with the advancement of the disease. The objective of this study was to present a primary *Corresponding author: progressive aphasia case followed due to conversion disorder and depression for Gülfizar Sözeri-Varma about 30 years and to discuss the confounding effects of the existing psychiatric symptoms at the diagnosis stage. [email protected] Keywords: Aphasia; Primer Progressive Aphasia (PPA); Depression; Conversion disorder Associate Professor, Faculty of Medicine, Department of Psychiatry, Pamukkale Received: May 17, 2017; Accepted: June 14, 2017; Published: June 20, 2017 Univercity, Turkey. Tel: +902582699000/4508 Introduction Primary Progressive Aphasia (PPA) is a neurodegenerative Citation: Yildirim M, Varma GS, Öncel C, disease that -
Case Report Huntington's Disease in a Patient Misdiagnosed As
Hindawi Case Reports in Psychiatry Volume 2018, Article ID 3915657, 4 pages https://doi.org/10.1155/2018/3915657 Case Report Huntington’s Disease in a Patient Misdiagnosed as Conversion Disorder João Machado Nogueira ,1 Ana Margarida Franco ,1 Susana Mendes,1 Anabela Valadas,2 Cristina Semedo,2 and Gustavo Jesus3 1 Department of Psychiatry and Mental Health, Setubal´ Hospital Center, Rua Camilo Castelo Branco, 2910-446 Setubal,´ Portugal 2Department of Neurology, Setubal´ Hospital Center, Rua Camilo Castelo Branco, 2910-446 Setubal,´ Portugal 3University Psychiatric Clinic, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal Correspondence should be addressed to Joao˜ Machado Nogueira; [email protected] and Ana Margarida Franco; [email protected] Joao˜ Machado Nogueira and Ana Margarida Franco contributed equally to this work. Received 6 October 2017; Revised 4 January 2018; Accepted 22 January 2018; Published 18 February 2018 Academic Editor: Toshiya Inada Copyright © 2018 Joao˜ Machado Nogueira et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Huntington’s disease (HD) is an inherited, progressive, and neurodegenerative neuropsychiatric disorder caused by the expansion of cytosine-adenine-guanine (CAG) trinucleotide in Interested Transcript (IT) 15 gene on chromosome 4. Tis pathology typically presents in individuals aged between 30 and 50 years and the age of onset is inversely correlated with the length of the CAG repeat expansion. It is characterized by chorea, cognitive defcits, and psychiatric symptoms. Usually the psychiatric disorders precede motor and cognitive impairment, Major Depressive Disorder and anxiety disorders being the most common presentations. -
16 Functional (Psychogenic) Movement Disorders
16 Functional (Psychogenic) Movement Disorders Professor MJ Edwards St George’s University Hospital, University of London, London UK Introduction Functional (psychogenic) disorders are common throughout neurological practice, and functional movement disorders (FMD) are a particularly common presentation. While they are often thought of as difficult to diagnose with confidence, but there are a number of clinical findings and targeted investigations that can aid diagnosis. Evidence regarding the best approach to treatment is still developing, but decent explanation of the diagnosis in a manner the patient can understand is clearly a rate limiting step in any move towards successful treatment. This is the job of the neurologist, and hence developing an understanding of this disorder is clearly important for all neurologists. Definitions One of the first issues to consider is the lack of consensus on what to call functional movement disorders. We have a number of words at our disposal, from “hysteria” (with all its unfortunate connotations regarding the source of these problems being the uterus), to functional, supratentorial, non-organic, and the latest contender: medically unexplained symptoms. We know already what patients think about these words, thanks to Stone et al (2002), and their study of “the number needed to offend”. Patients attending a neurology clinic were asked “if your doctor said you had X, would you think he was suggesting that you were (or had) Y. Words which patients felt meant that the doctor was suggesting that they were “putting it on”, “mad”, or that “symptoms were all in the mind” were judged offensive. Of the commonly used euphemisms for psychogenic illness, “functional” came out best of all, with “hysteria” and “medically unexplained symptoms” causing almost the same amount of “offence”. -
Chapter DHS 146 VACCINE−PREVENTABLE DISEASES
Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau. 271 DEPARTMENT OF HEALTH SERVICES DHS 146.04 Chapter DHS 146 VACCINE−PREVENTABLE DISEASES DHS 146.01 Authority and purpose. DHS 146.03 Vaccine−preventable diseases. DHS 146.02 Definitions. DHS 146.04 Purchase and distribution of vaccines. Note: Chapter HSS 146 was created as an emergency rule effective August 25, (8) Meningitis. 1994. Chapter HSS 146 was renumbered chapter HFS 146 under s. 13.93 (2m) (b) 1., Stats., Register, November, 1996, No. 491. Chapter HFS 146 was renumbered (9) Mumps. chapter DHS 146 under s. 13.92 (4) (b) 1., Stats., and corrections made under s. 13.92 (10) Pertussis (whooping cough). (4) (b) 7., Stats., Register January 2009 No. 637. (11) Pneumococcal. DHS 146.01 Authority and purpose. This chapter is (12) Poliomyelitis. promulgated under the authority of s. 252.04 (1) and (10), Stats., (13) Rabies. to specify vaccine−preventable diseases in addition to those listed (14) Rotavirus. in s. 252.04 (1), Stats. The department is directed by s. 252.04 (1), Stats., to carry out a statewide immunization program to eliminate (15) Rubella (German measles). vaccine−preventable diseases or otherwise protect people from (16) Tetanus. them, and by s. 252.04 (8), Stats., to provide vaccines without (17) Varicella (chickenpox). charge to immunize people against those diseases, if federal or (18) Zoster (shingles). state funds are available to purchase the vaccines and if a school Note: This is not the list of diseases for which immunizations are required as a con- district or local health department requests the vaccines and the dition of admission to an elementary, middle, junior high or senior high school or a local immunization effort is supervised by a physician. -
Psychogenic Movement Disorders Amitabh Gupta and Anthony E
Psychogenic movement disorders Amitabh Gupta and Anthony E. Lang Movement Disorders Unit, Toronto Western Hospital, Purpose of review University of Toronto, Ontario, Canada This review summarizes the progress made in the area of psychogenic movement Correspondence to Dr Anthony E. Lang, MD, FRCPC, disorders (PMDs) over the past 2 years, and a simplified classification of diagnostic Director, Movement Disorders Unit, Toronto Western Hospital, 399 Bathurst Street, McLaughlin 7-418, certainty is proposed that incorporates electrophysiological assessment. Toronto M5T 2S8, Ontario, Canada Recent findings Tel: +1 416 603 6422; fax: +1 416 603 5004; e-mail: [email protected] Functional magnetic resonance imaging studies have demonstrated altered blood flow in conversion disorders that may reflect changes in synaptic activity. Current Opinion in Neurology 2009, 22:430–436 Electrophysiological testing shows limitations in distinguishing between psychogenic and organic propriospinal myoclonus and dystonia. Recent evidence cautions against the uncritical acceptance of all cases of posttraumatic myoclonus and ‘jumpy stump’ as being organic in nature. ‘Essential palatal tremor’ is recognized as a rather heterogeneous group of tremors that includes psychogenic tremor. Two recent studies evaluating the long-term prognosis of psychogenic tremor differ in the degree of unfavorable outcome. Different groups of PMDs might have distinctive gait characteristics with prognostic, diagnostic, or therapeutic value. Two recent reviews provide comprehensive information on the understudied area of PMDs in children. Summary The diagnosis of PMDs should not be regarded as a diagnosis of exclusion. Careful clinical assessment is critical, and imaging or electrophysiological studies may provide important insights and confirmation of the diagnosis though some cases remain challenging and current assessments fail to provide needed clarification. -
ICD-10 International Statistical Classification of Diseases and Related Health Problems
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.